US 10759759
Prodrugs of kallikrein inhibitors
granted A61PA61P29/00
Quick answer
US patent 10759759 (Prodrugs of kallikrein inhibitors) held by BioCryst Pharmaceuticals, Inc. expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BioCryst Pharmaceuticals, Inc.
- Grant date
- Tue Sep 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61P, A61P29/00